Challenges in the Management of the Post-Transplant Period in Modern Transplantology
DOI:
https://doi.org/10.51699/cajmns.v7i2.3123Keywords:
Transplantation, Postoperative Care, Immunosuppression, Long-Term Follow-up, Patient Management, Multidisciplinary CareAbstract
The post-transplant period is a defining moment in the evolution of contemporary transplantology and is largely responsible for long-term clinical outcomes and patient survival. While great progress in surgical techniques and perioperative management has been made and has led to better early post-transplant success, the success of transplantation is increasingly dependent on comprehensive and sustained management after surgery. The post-transplant period is marked by constant physiological adaptation, long-term immunosuppression, and the requirement for meticulous clinical surveillance, which is a complex and highly individualised period. This narrative review is an attempt to address the major problems that come with managing the post-transplant period in contemporary transplantology without a focus on a specific transplanted organ. The review synthesises the current state of the art that addresses some of the key aspects of post-transplant care, including the optimisation of immunosuppressive regimen, prevention and early identification of infectious complications, management of metabolic and systemic changes, patient adherence and the importance of multidisciplinary follow-up. The dynamic nature of post-transplant care and inherent limitations of the uniform management protocols are emphasised. The literature analysed points to the effect of long-term outcomes being strongly affected by individualised and patient-centred management approaches as opposed to standardised practices only. Immunosuppressive regimens require constant adjustment in order to maintain the balance of immunity yet minimise adverse effects. Infectious complications often have atypical clinical manifestations, underlining the necessity for active monitoring instead of treatment based on symptoms. In addition, metabolic disturbances and psychosocial factors become important contributors to morbidity and decreased quality of life among transplant recipients.
References
Morris PJ, Knechtle SJ. Kidney Transplantation: Principles and Practice. 7th ed. Philadelphia: Elsevier Saunders; 2014.
Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.
Halloran PF. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine. 2004;351(26):2715–2729.
Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress? American Journal of Transplantation. 2004;4(1):1–8.
Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence. BMJ. 2005;331(7524):1064–1065.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses. PLoS Medicine. 2009;6(7):e1000097.
Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.
Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Journal of Epidemiology and Community Health. 2006;60(5):367–372.
Halloran PF. Immunosuppressive drugs for kidney transplantation. New England Journal of Medicine. 2004;351(26):2715–2729.
Fishman JA. Infection in solid-organ transplant recipients. New England Journal of Medicine. 2007;357(25):2601–2614.
Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after transplantation. American Journal of Transplantation. 2003;3(2):178–185.
Dew MA, DiMartini AF, De Vito Dabbs A, et al. Adherence to the medical regimen during the first two years after transplantation. Transplantation. 2007;83(7):858–873.
Rodrigue JR, Mandelbrot DA, Hanto DW. A cross-sectional study of fatigue and sleep quality before and after transplantation. Clinical Transplantation. 2011;25(1):E13–E21.
Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress? American Journal of Transplantation. 2004;4(1):1–8.
Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. New England Journal of Medicine. 2007;357(25):2562–2575.
Kotton CN. Management of cytomegalovirus infection in solid organ transplantation. Nature Reviews Nephrology. 2010;6(12):711–721.
Opelz G, Döhler B. Influence of immunosuppressive regimens on graft survival. Transplantation. 2004;78(6):778–784.
Gordon EJ, Prohaska TR, Gallant MP, et al. Longitudinal analysis of transplant recipients’ self-care behaviors. American Journal of Transplantation. 2009;9(4):907–915.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Matkarimov Bakhtiyorjon Khalmirzayevich

This work is licensed under a Creative Commons Attribution 4.0 International License.


